Characterization of a Non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in paget's disease of bone

Dereen Najat, Thomas P. Garner, Thilo Hagen, Barry Shaw, Paul W. Sheppard, Alberto Falchetti, Francesca Marini, Maria L. Brandi, Jed E. Long, James R. Cavey, Mark S. Searle, Robert Layfield

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Mutations affecting the ubiquitin-associated (UBA) domain of sequestosome 1 (SQSTMl/p62) are commonly found in Paget's disease of bone (PDB) and impair SQSTMl's ability to bind ubiquitin, resulting in dysregulated NF-kB signaling. In contrast, non-UBA domain mutations are rarer, and little is known about how they manifest their effects. We present the first characterization at the molecular, cellular, and functional level of a non-UBA domain missense mutation (A381V) of SQSTM1. Direct sequencing of exon 7 of the SQSTM1 gene in an Italian PDB patient detected a heterozygous C to T transversion at position 1182, resulting in an alanine to valine substitution at codon 381. Pull-down assays showed the non-UBA region of SQSTM1 that contains A381 is important in mediating ubiquitin-binding affinity and that the A381V mutation exerts weak negative effects on ubiquitin binding. Structural and binding analyses of longer UBA constructs containing A381, using NMR spectroscopy and circular dichroism, showed this region of the protein to be largely unstructured and confirmed its contribution to increased ubiquitin-binding affinity. Co-transfections of U20S cells showed that the A381V mutant SQSTM1 co-localized with ubiquitin with a cellular phenotype indistinguishable from wildtype. Finally, effects of the wildtype and mutant SQSTM1 on NF-κB signaling were assessed in HEK293 cells co-transfected with an NF-κB luciferase reporter construct. A381V mutant SQSTM1 produced a level of activation of NF-κB signaling greater than wildtype and similar to that of UBA domain mutants, indicating that non-UBA and UBA domain mutations may exert their effects through a common mechanism involving dysregulated NF-κB signaling.

Original languageEnglish (US)
Pages (from-to)632-642
Number of pages11
JournalJournal of Bone and Mineral Research
Volume24
Issue number4
DOIs
StatePublished - Apr 2009
Externally publishedYes

Fingerprint

Osteitis Deformans
Missense Mutation
Ubiquitin
Mutation
NF-kappa B
HEK293 Cells
Valine
Circular Dichroism
Luciferases
Codon
Alanine
Transfection
Exons
Magnetic Resonance Spectroscopy
Phenotype

Keywords

  • NF-κb
  • P62
  • Paget's disease of bone
  • SQSTM1
  • Ubiquitin

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Najat, D., Garner, T. P., Hagen, T., Shaw, B., Sheppard, P. W., Falchetti, A., ... Layfield, R. (2009). Characterization of a Non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in paget's disease of bone. Journal of Bone and Mineral Research, 24(4), 632-642. https://doi.org/10.1359/jbmr.081204

Characterization of a Non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in paget's disease of bone. / Najat, Dereen; Garner, Thomas P.; Hagen, Thilo; Shaw, Barry; Sheppard, Paul W.; Falchetti, Alberto; Marini, Francesca; Brandi, Maria L.; Long, Jed E.; Cavey, James R.; Searle, Mark S.; Layfield, Robert.

In: Journal of Bone and Mineral Research, Vol. 24, No. 4, 04.2009, p. 632-642.

Research output: Contribution to journalArticle

Najat, D, Garner, TP, Hagen, T, Shaw, B, Sheppard, PW, Falchetti, A, Marini, F, Brandi, ML, Long, JE, Cavey, JR, Searle, MS & Layfield, R 2009, 'Characterization of a Non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in paget's disease of bone', Journal of Bone and Mineral Research, vol. 24, no. 4, pp. 632-642. https://doi.org/10.1359/jbmr.081204
Najat, Dereen ; Garner, Thomas P. ; Hagen, Thilo ; Shaw, Barry ; Sheppard, Paul W. ; Falchetti, Alberto ; Marini, Francesca ; Brandi, Maria L. ; Long, Jed E. ; Cavey, James R. ; Searle, Mark S. ; Layfield, Robert. / Characterization of a Non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in paget's disease of bone. In: Journal of Bone and Mineral Research. 2009 ; Vol. 24, No. 4. pp. 632-642.
@article{01758d1b303e412880dae775774d0936,
title = "Characterization of a Non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in paget's disease of bone",
abstract = "Mutations affecting the ubiquitin-associated (UBA) domain of sequestosome 1 (SQSTMl/p62) are commonly found in Paget's disease of bone (PDB) and impair SQSTMl's ability to bind ubiquitin, resulting in dysregulated NF-kB signaling. In contrast, non-UBA domain mutations are rarer, and little is known about how they manifest their effects. We present the first characterization at the molecular, cellular, and functional level of a non-UBA domain missense mutation (A381V) of SQSTM1. Direct sequencing of exon 7 of the SQSTM1 gene in an Italian PDB patient detected a heterozygous C to T transversion at position 1182, resulting in an alanine to valine substitution at codon 381. Pull-down assays showed the non-UBA region of SQSTM1 that contains A381 is important in mediating ubiquitin-binding affinity and that the A381V mutation exerts weak negative effects on ubiquitin binding. Structural and binding analyses of longer UBA constructs containing A381, using NMR spectroscopy and circular dichroism, showed this region of the protein to be largely unstructured and confirmed its contribution to increased ubiquitin-binding affinity. Co-transfections of U20S cells showed that the A381V mutant SQSTM1 co-localized with ubiquitin with a cellular phenotype indistinguishable from wildtype. Finally, effects of the wildtype and mutant SQSTM1 on NF-κB signaling were assessed in HEK293 cells co-transfected with an NF-κB luciferase reporter construct. A381V mutant SQSTM1 produced a level of activation of NF-κB signaling greater than wildtype and similar to that of UBA domain mutants, indicating that non-UBA and UBA domain mutations may exert their effects through a common mechanism involving dysregulated NF-κB signaling.",
keywords = "NF-κb, P62, Paget's disease of bone, SQSTM1, Ubiquitin",
author = "Dereen Najat and Garner, {Thomas P.} and Thilo Hagen and Barry Shaw and Sheppard, {Paul W.} and Alberto Falchetti and Francesca Marini and Brandi, {Maria L.} and Long, {Jed E.} and Cavey, {James R.} and Searle, {Mark S.} and Robert Layfield",
year = "2009",
month = "4",
doi = "10.1359/jbmr.081204",
language = "English (US)",
volume = "24",
pages = "632--642",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Characterization of a Non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in paget's disease of bone

AU - Najat, Dereen

AU - Garner, Thomas P.

AU - Hagen, Thilo

AU - Shaw, Barry

AU - Sheppard, Paul W.

AU - Falchetti, Alberto

AU - Marini, Francesca

AU - Brandi, Maria L.

AU - Long, Jed E.

AU - Cavey, James R.

AU - Searle, Mark S.

AU - Layfield, Robert

PY - 2009/4

Y1 - 2009/4

N2 - Mutations affecting the ubiquitin-associated (UBA) domain of sequestosome 1 (SQSTMl/p62) are commonly found in Paget's disease of bone (PDB) and impair SQSTMl's ability to bind ubiquitin, resulting in dysregulated NF-kB signaling. In contrast, non-UBA domain mutations are rarer, and little is known about how they manifest their effects. We present the first characterization at the molecular, cellular, and functional level of a non-UBA domain missense mutation (A381V) of SQSTM1. Direct sequencing of exon 7 of the SQSTM1 gene in an Italian PDB patient detected a heterozygous C to T transversion at position 1182, resulting in an alanine to valine substitution at codon 381. Pull-down assays showed the non-UBA region of SQSTM1 that contains A381 is important in mediating ubiquitin-binding affinity and that the A381V mutation exerts weak negative effects on ubiquitin binding. Structural and binding analyses of longer UBA constructs containing A381, using NMR spectroscopy and circular dichroism, showed this region of the protein to be largely unstructured and confirmed its contribution to increased ubiquitin-binding affinity. Co-transfections of U20S cells showed that the A381V mutant SQSTM1 co-localized with ubiquitin with a cellular phenotype indistinguishable from wildtype. Finally, effects of the wildtype and mutant SQSTM1 on NF-κB signaling were assessed in HEK293 cells co-transfected with an NF-κB luciferase reporter construct. A381V mutant SQSTM1 produced a level of activation of NF-κB signaling greater than wildtype and similar to that of UBA domain mutants, indicating that non-UBA and UBA domain mutations may exert their effects through a common mechanism involving dysregulated NF-κB signaling.

AB - Mutations affecting the ubiquitin-associated (UBA) domain of sequestosome 1 (SQSTMl/p62) are commonly found in Paget's disease of bone (PDB) and impair SQSTMl's ability to bind ubiquitin, resulting in dysregulated NF-kB signaling. In contrast, non-UBA domain mutations are rarer, and little is known about how they manifest their effects. We present the first characterization at the molecular, cellular, and functional level of a non-UBA domain missense mutation (A381V) of SQSTM1. Direct sequencing of exon 7 of the SQSTM1 gene in an Italian PDB patient detected a heterozygous C to T transversion at position 1182, resulting in an alanine to valine substitution at codon 381. Pull-down assays showed the non-UBA region of SQSTM1 that contains A381 is important in mediating ubiquitin-binding affinity and that the A381V mutation exerts weak negative effects on ubiquitin binding. Structural and binding analyses of longer UBA constructs containing A381, using NMR spectroscopy and circular dichroism, showed this region of the protein to be largely unstructured and confirmed its contribution to increased ubiquitin-binding affinity. Co-transfections of U20S cells showed that the A381V mutant SQSTM1 co-localized with ubiquitin with a cellular phenotype indistinguishable from wildtype. Finally, effects of the wildtype and mutant SQSTM1 on NF-κB signaling were assessed in HEK293 cells co-transfected with an NF-κB luciferase reporter construct. A381V mutant SQSTM1 produced a level of activation of NF-κB signaling greater than wildtype and similar to that of UBA domain mutants, indicating that non-UBA and UBA domain mutations may exert their effects through a common mechanism involving dysregulated NF-κB signaling.

KW - NF-κb

KW - P62

KW - Paget's disease of bone

KW - SQSTM1

KW - Ubiquitin

UR - http://www.scopus.com/inward/record.url?scp=65549140668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549140668&partnerID=8YFLogxK

U2 - 10.1359/jbmr.081204

DO - 10.1359/jbmr.081204

M3 - Article

C2 - 19049332

AN - SCOPUS:65549140668

VL - 24

SP - 632

EP - 642

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 4

ER -